BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15890667)

  • 1. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?
    Copie-Bergman C; Locher C; Levy M; Chaumette MT; Haioun C; Delfau-Larue MH; Leroy K; Gaulard P; Delchier JC
    Ann Oncol; 2005 Aug; 16(8):1232-6. PubMed ID: 15890667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
    Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
    Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.
    Wündisch T; Dieckhoff P; Greene B; Thiede C; Wilhelm C; Stolte M; Neubauer A
    Gastroenterology; 2012 Oct; 143(4):936-42; quiz e13-4. PubMed ID: 22750463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
    Morgner A; Bayerdörffer E; Neubauer A; Stolte M
    Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.
    Morgner A; Miehlke S; Stolte M; Neubauer A; Alpen B; Thiede C; Klann H; Hierlmeier FX; Ell C; Ehninger G; Bayerdörffer E
    World J Gastroenterol; 2001 Apr; 7(2):248-53. PubMed ID: 11819769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori eradication for gastric MALT lymphoma].
    Nakamura S; Matsumoto T; Kitazono T
    Nihon Rinsho; 2013 Aug; 71(8):1424-8. PubMed ID: 23967674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
    Montalban C; Norman F
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.
    Morgner A; Thiede C; Bayerdörffer E; Alpen B; Wündisch T; Neubauer A; Stolte M
    Curr Gastroenterol Rep; 2001 Dec; 3(6):516-22. PubMed ID: 11696290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].
    Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ
    Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.